Is Eli Lilly Stock Outperforming the Dow?

Indianapolis, Indiana-based Eli Lilly and Company (LLY) discovers, develops, manufactures, and markets human pharmaceutical products in the United States and internationally. The company has a market cap of $1.1 trillion and offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, and more.

Companies with a market cap of $200 billion or more are typically referred to as “mega-cap stocks.” LLY fits squarely into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the general drug manufacturers industry.